Investor worries have resulted in a selloff in health care machine makers, sending iShares US Professional medical Products exchange-traded fund down seven for every cent this 12 months. Fund professionals could continue to be concerned about buying stocks perceived for being Among the many “GLP-1 losers,” mentioned HSBC analyst Rajesh Kumar.It